Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Vasopressin-2 Antagonist Tolvaptan and Fluid Restriction in the Treatment of Hyponatremia Following Pituitary Surgery

NCT04119206 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.

NCT NCT04119206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Vasopressin-2 Antagonist Tolvaptan and Fluid Restriction in the Treatment of Hyponatremia Following Pituitary Surgery
Lead sponsor
University of Erlangen-Nürnberg Medical School
Phase
Observational
Overall status
Completed
Start date
January 1, 2009
Completion date
December 31, 2013
Enrollment
334 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyponatremia, pituitary, syndrome of inappropriate adh (siadh) secretion